Papers: 28 Feb 2014 - 7 Mar 2014 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes. Sormani M P, De Stefano N Mult Scler. 2014 Mar; 20(3):280-1. PMID: 24589685. Abstract Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis. Hanson RL, Habibi M, Khamo N, Abdou S, Stubbings J Am J Health Syst Pharm. 2014 Mar 1; 71(6):463-9. PMID: 24589537. Abstract MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No. Ebers GC Mult Scler. 2014 Mar; 20(3):282-3. PMID: 24589686. Abstract Lipoprotein-associated lysolipids are differentially involved in high-density lipoprotein- and its oxidized form-induced neurite remodeling in PC12 cells. Sato K, Tobo M, Mogi C, Murata N, Kotake M, Kuwabara A, Im D-S, Okajima F Neurochem Int. 2014 Feb 28; 68C:38-47. PMID: 24589770. Abstract Bullous pemphigoid in a patient with multiple sclerosis being treated with human immunoglobulin. Massa AF, Varela P, Osório-Ferreira E, Nora M, Couceiro A, Baptista A J Eur Acad Dermatol Venereol. 2014 Mar 4. PMID: 24588974. Abstract To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis. Schirmer L, Srivastava R, Hemmer B Mult Scler. 2014 Mar; 20(3):271-9. PMID: 24589684. Abstract Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study. Gold R, Comi G, Palace J, Siever A, Gottschalk R, Bijarnia M, von Rosenstiel P, Tomic D, Kappos L, For the FIRST Study Investigators J Neurol. 2014 Mar 4. PMID: 24590403. Abstract Mechanisms and Pharmacology of Neuropathic Pain in Multiple Sclerosis. Iannitti T, Kerr BJ, Taylor BK Curr Top Behav Neurosci. 2014 Mar 4. PMID: 24590824. Abstract MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge. Jacobsen CO, Farbu E Acta Neurol Scand Suppl. 2014 Apr(198):32-6. PMID: 24588504. Abstract Brain Innate Immunity In The Regulation Of Neuroinflammation: Therapeutic Strategies By Modulating Cd200-Cd200r Interaction Involve The Cannabinoid System. Hernangomez M, Carrillo-Salinas FJ, Mecha M, Correa F, Mestre L, Loria F, Feliu A, Docagne F, Guaza C Curr Pharm Des. 2014 Jan 30. PMID: 24588829. Abstract Tecfidera(®): an approach for repurposing. Spencer RP Pharm Pat Anal. 2014 Mar; 3(2):183-98. PMID: 24588595. Abstract Role of toll-like receptor 2 in ischemic demyelination and oligodendrocyte death. Choi J Y, Cui Y, Kang Y M, Kim J-H, Lee S J, Kim BG Neurobiol Aging. 2014 Feb 5. PMID: 24589120. Abstract Neurological disorders in the Global Burden of Disease 2010 study. Stovner LJ, Hoff JM, Svalheim S, Gilhus NE Acta Neurol Scand Suppl. 2014 Apr(198):1-6. PMID: 24588499. Abstract Variables associated with patient activation in persons with multiple sclerosis. Goodworth M-CR, Stepleman L, Hibbard J, Johns L, Wright D, Hughes MD, Williams MJ J Health Psychol. 2014 Mar 3. PMID: 24591120. Abstract Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis? Di Maggio G, Santangelo R, Guerrieri S, Bianco M, Ferrari L, Medaglini S, Rodegher M, Colombo B, Moiola L, Chieffo R, et al. Mult Scler. 2014 Mar 3. PMID: 24591532. Abstract Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner. Oreja-Guevara C, Wiendl H, Kieseier BC, Airas L, for the NeuroNet Study Group Ther Adv Neurol Disord. 2014 Mar; 7(2):137-149. PMID: 24587828. Abstract Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies. Tsivgoulis G, Sergentanis TN, Chan A, Voumvourakis K, Triantafyllou N, Psaltopoulou T, Gold R, Krogias C Ther Adv Neurol Disord. 2014 Mar; 7(2):114-136. PMID: 24587827. Abstract A Case of Anti-aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló Concentric Lesions. Mori M, Masuda H Intern Med. 2014; 53(5):531. PMID: 24583454. Abstract Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid. Long Y, Chen M, Zhang B, Gao C, Zheng Y, Xie L, Gao Q, Yin J J Neuroimmunol. 2014 Feb 16. PMID: 24582827. Abstract Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis. Berkovich R, Agius MA Ther Adv Neurol Disord. 2014 Mar; 7(2):83-96. PMID: 24587825. Abstract CNS inflammation other than multiple sclerosis: How likely is diagnosis? Street D, Halfpenny CA, Galea I Neurology. 2014 Feb 28. PMID: 24587479. Abstract Plantarflexor weakness negatively impacts walking in persons with multiple sclerosis more than plantarflexor spasticity. Wagner JM, Kremer TR, Van Dillen LR, Naismith RT Arch Phys Med Rehabil. 2014 Feb 27. PMID: 24582617. Abstract Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress. Bahamonde C, Conde C, Agüera E, Lillo R, Luque E, Gascón F, Feijóo M, Cruz AH, Sánchez-López F, Túnez I Eur J Pharmacol. 2014 Feb 25; 730C:26-30. PMID: 24582759. Abstract First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks. Nicholas J A, Racke M K, Imitola J, Boster A L Ther Adv Chronic Dis. 2014 Mar; 5(2):62-68. PMID: 24587891. Abstract Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis. Miyamoto K, Tanaka N, Moriguchi K, Ueno R, Kadomatsu K, Kitagawa H, Kusunoki S Glycobiology. 2014 Feb 28. PMID: 24584141. Abstract Gait kinematics of people with Multiple Sclerosis and the acute application of Functional Electrical Stimulation. van der Linden ML, Scott SM, Hooper JE, Cowan P, Mercer TH Gait Posture. 2014 Feb 6. PMID: 24582514. Abstract 4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review. Jensen H B, Ravnborg M, Dalgas U, Stenager E Ther Adv Neurol Disord. 2014 Mar; 7(2):97-113. PMID: 24587826. Abstract Novel insights into the development and maintenance of the blood-brain barrier. Engelhardt B, Liebner S Cell Tissue Res. 2014 Mar 4. Epub 2014 Mar 04. PMID: 24590145. Abstract A subtraction pipeline for automatic detection of new appearing multiple sclerosis lesions in longitudinal studies. Ganiler O, Oliver A, Diez Y, Freixenet J, Vilanova JC, Beltran B, Ramió-Torrentà L, Rovira A, Lladó X Neuroradiology. 2014 Mar 4. Epub 2014 Mar 04. PMID: 24590302. Abstract Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation. Shrestha B, Ge S, Pachter JS Fluids Barriers CNS. 2014; 11(1):6. Epub 2014 Mar 04. PMID: 24589378. Abstract LINGO-1 regulates oligodendrocyte differentiation by inhibiting ErbB2 translocation and activation in lipid rafts. Lee X, Shao Z, Sheng G, Pepinsky B, Mi S Mol Cell Neurosci. 2014 Feb 28. PMID: 24583087. Abstract Biomarkers for multiple sclerosis. Tomioka R, Matsui M Intern Med. 2014; 53(5):361-5. PMID: 24583421. Abstract Anti-aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló's Concentric Lesions. Zhou C, Yang Y, Zhang H Intern Med. 2014; 53(5):529. PMID: 24583453. Abstract Relapsing-Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells. Sasaki K, Bean A, Shah S, Schutten E, Huseby PG, Peters B, Shen ZT, Vanguri V, Liggitt D, Huseby ES J Immunol. 2014 Apr 1; 192(7):3029-42. Epub 2014 Mar 03. PMID: 24591371. Abstract The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells. Ganor Y, Levite M J Neural Transm. 2014 Mar 2. Epub 2014 Mar 02. PMID: 24584970. Abstract Sulfatide-mediated control of extracellular matrix-dependent oligodendrocyte maturation. Baron W, Bijlard M, Nomden A, de Jonge JC, Teunissen CE, Hoekstra D Glia. 2014 Feb 28. PMID: 24578319. Abstract Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits. Lauer K Int J Mol Sci. 2014; 15(3):3533-45. PMID: 24577315. Abstract Fast computation of myelin maps from MRI T2 relaxation data using multicore CPU and graphics card parallelization. Yoo Y, Prasloski T, Vavasour I, Mackay A, Traboulsee AL, Li DKB, Tam RC J Magn Reson Imaging. 2014 Feb 27. PMID: 24578324. Abstract Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes. Mitjana R, Tintoré M, Rocca MA, Auger C, Barkhof F, Filippi M, Polman C, Fazekas F, Huerga E, Montalban X, et al. Mult Scler. 2014 Feb 27. PMID: 24576831. Abstract Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab. Kitley J, Evangelou N, Küker W, Jacob A, Leite IM, Palace J J Neurol Sci. 2014 Feb 4. PMID: 24576801. Abstract Adverse socioeconomic position during the life course is associated with multiple sclerosis. Briggs FBS, Acuña BS, Shen L, Bellesis KH, Ramsay PP, Quach H, Bernstein A, Schaefer C, Barcellos LF J Epidemiol Community Health. 2014 Feb 27. PMID: 24577137. Abstract HLA-DRB1*15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer. Anagnostouli M, Anagnostoulis G, Katsavos S, Panagiotou M, Kararizou E, Davaki P J Neurol Sci. 2014 Feb 11. PMID: 24576802. Abstract Optic and auditory pathway dysfunction in demyelinating neuropathies. Knopp M, Leese RJ, Martin-Lamb D, Rajabally YA Acta Neurol Scand. 2014 Feb 20. PMID: 24571608. Abstract Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats. Bucher T, Dubreil L, Colle M-A, Maquigneau M, Deniaud J, Ledevin M, Moullier P, Joussemet B Gene Ther. 2014 Feb 27. PMID: 24572783. Abstract Human Herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via TLR9. Reynaud JM, Jégou J-F, Welsch J, Horvat B J Virol. 2014 Feb 26. PMID: 24574405. Abstract Treatment satisfaction, adherence and behavioral assessment in patients de - escalating from natalizumab to interferon beta. Zecca C, Riccitelli GC, Calabrese P, Pravatà E, Candrian U, Guttmann CRG, Gobbi C BMC Neurol. 2014; 14(1):38. Epub 2014 Feb 28. PMID: 24576156. Abstract Targeting FcRn for therapy: From live cell imaging to in vivo studies in mice. Ward SE, Velmurugan R, Ober RJ Immunol Lett. 2014 Feb 23. PMID: 24572175. Abstract Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression. Irizar H, Muñoz-Culla M, Sepúlveda L, Sáenz-Cuesta M, Prada A, Castillo-Triviño T, Zamora-López G, de Munain A L, Olascoaga J, Otaegui D PLoS One. 2014; 9(2):e90482. Epub 2014 Feb 28. PMID: 24587374. Abstract Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis. Williams SK, Maier O, Fischer R, Fairless R, Hochmeister S, Stojic A, Pick L, Haar D, Musiol S, Storch MK, et al. PLoS One. 2014; 9(2):e90117. Epub 2014 Feb 28. PMID: 24587232. Abstract Family studies of type 1 diabetes reveal additive and epistatic effects between MGAT1 and three other polymorphisms. Yu Z, Li CF, Mkhikian H, Zhou RW, Newton BL, Demetriou M Genes Immun. 2014 Feb 27. PMID: 24572742. Abstract Modulation of subventricular zone oligodendrogenesis: a role for hemopressin? Xapelli S, Agasse F, Grade S, Bernardino L, Ribeiro FF, Schitine CS, Heimann AS, Ferro ES, Sebasti AM, De Melo Reis RA, et al. Front Cell Neurosci. 2014; 8:59. Epub 2014 Feb 27. PMID: 24578683. Abstract Glatiramer acetate does not protect from acute ischemic stroke in mice. Kraft P, Göbel K, Meuth SG, Kleinschnitz C Exp Transl Stroke Med. 2014; 6(1):4. Epub 2014 Feb 27. PMID: 24576335. Abstract Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis. Ghassemi R, Narayanan S, Banwell B, Sled JG, Shroff M, Arnold DL, Canadian Pediatric Demyelinating Disease Network PLoS One. 2014; 9(2):e85741. Epub 2014 Feb 26. PMID: 24586244. Abstract Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors b20-4.1.1 and angiostatin (k1-3). Macmillan CJ, Doucette CD, Warford J, Furlong SJ, Hoskin DW, Easton AS PLoS One. 2014; 9(2):e89770. Epub 2014 Feb 26. PMID: 24587024. Abstract Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways. Arnold P, Mojumder D, Detoledo J, Lucius R, Wilms H Clin Pharmacol. 2014; 6:35-42. Epub 2014 Feb 24. PMID: 24591852. Abstract Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta. Gavasso S, Mosleth E F, Marøy T, Jørgensen K, Nakkestad H-L, Gjertsen B-T, Myhr K-M, Vedeler C PLoS One. 2014; 9(2):e88632. Epub 2014 Feb 19. PMID: 24586361. Abstract Inflammatory Cytokines and Physical Activity in Multiple Sclerosis. Florindo M ISRN Neurol. 2014; 2014:151572. Epub 2014 Jan 27. PMID: 24592334. Abstract A Mushroom Extract Piwep from Phellinus igniarius Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Immune Cell Infiltration in the Spinal Cord. Li L, Wu G, Choi B Y, Jang B G, Kim J H, Sung G H, Cho J Y, Suh S W, Park H J Biomed Res Int. 2014; 2014:218274. Epub 2014 Jan 27. PMID: 24592383. Abstract Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI. Messina S, Patti F Mult Scler Int. 2014; 2014:609694. Epub 2014 Jan 22. PMID: 24587905. Abstract Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait. Lamdhade S, Ashkanani A, Alroughani R ISRN Neurol. 2014; 2014:861091. Epub 2014 Jan 22. PMID: 24587917. Abstract Neurosarcoidosis mimicking multiple sclerosis successfully treated with methotrexate and adalimumab. Metyas S, Tawadrous M, Yeter KC, Arkfeld DG Int J Rheum Dis. 2014 Feb; 17(2):214-6. Epub 2013 Jul 02. PMID: 24576278. Abstract Assessment of ovarian reserve and Doppler characteristics in patients with multiple sclerosis using immunomodulating drugs. Cil A P, Leventoğlu A, Sönmezer M, Soylukoç R, Oktay K J Turk Ger Gynecol Assoc. 2009; 10(4):213-9. Epub 2009 Dec 01. PMID: 24591875. Abstract Multiple-Sklerose-Therapie-Konsensus-Gruppe Nervenarzt. 2002 Jun; 73(6):556-563. PMID: 24577618. Abstract
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes. Sormani M P, De Stefano N Mult Scler. 2014 Mar; 20(3):280-1. PMID: 24589685. Abstract
Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis. Hanson RL, Habibi M, Khamo N, Abdou S, Stubbings J Am J Health Syst Pharm. 2014 Mar 1; 71(6):463-9. PMID: 24589537. Abstract
MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No. Ebers GC Mult Scler. 2014 Mar; 20(3):282-3. PMID: 24589686. Abstract
Lipoprotein-associated lysolipids are differentially involved in high-density lipoprotein- and its oxidized form-induced neurite remodeling in PC12 cells. Sato K, Tobo M, Mogi C, Murata N, Kotake M, Kuwabara A, Im D-S, Okajima F Neurochem Int. 2014 Feb 28; 68C:38-47. PMID: 24589770. Abstract
Bullous pemphigoid in a patient with multiple sclerosis being treated with human immunoglobulin. Massa AF, Varela P, Osório-Ferreira E, Nora M, Couceiro A, Baptista A J Eur Acad Dermatol Venereol. 2014 Mar 4. PMID: 24588974. Abstract
To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis. Schirmer L, Srivastava R, Hemmer B Mult Scler. 2014 Mar; 20(3):271-9. PMID: 24589684. Abstract
Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study. Gold R, Comi G, Palace J, Siever A, Gottschalk R, Bijarnia M, von Rosenstiel P, Tomic D, Kappos L, For the FIRST Study Investigators J Neurol. 2014 Mar 4. PMID: 24590403. Abstract
Mechanisms and Pharmacology of Neuropathic Pain in Multiple Sclerosis. Iannitti T, Kerr BJ, Taylor BK Curr Top Behav Neurosci. 2014 Mar 4. PMID: 24590824. Abstract
MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge. Jacobsen CO, Farbu E Acta Neurol Scand Suppl. 2014 Apr(198):32-6. PMID: 24588504. Abstract
Brain Innate Immunity In The Regulation Of Neuroinflammation: Therapeutic Strategies By Modulating Cd200-Cd200r Interaction Involve The Cannabinoid System. Hernangomez M, Carrillo-Salinas FJ, Mecha M, Correa F, Mestre L, Loria F, Feliu A, Docagne F, Guaza C Curr Pharm Des. 2014 Jan 30. PMID: 24588829. Abstract
Tecfidera(®): an approach for repurposing. Spencer RP Pharm Pat Anal. 2014 Mar; 3(2):183-98. PMID: 24588595. Abstract
Role of toll-like receptor 2 in ischemic demyelination and oligodendrocyte death. Choi J Y, Cui Y, Kang Y M, Kim J-H, Lee S J, Kim BG Neurobiol Aging. 2014 Feb 5. PMID: 24589120. Abstract
Neurological disorders in the Global Burden of Disease 2010 study. Stovner LJ, Hoff JM, Svalheim S, Gilhus NE Acta Neurol Scand Suppl. 2014 Apr(198):1-6. PMID: 24588499. Abstract
Variables associated with patient activation in persons with multiple sclerosis. Goodworth M-CR, Stepleman L, Hibbard J, Johns L, Wright D, Hughes MD, Williams MJ J Health Psychol. 2014 Mar 3. PMID: 24591120. Abstract
Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis? Di Maggio G, Santangelo R, Guerrieri S, Bianco M, Ferrari L, Medaglini S, Rodegher M, Colombo B, Moiola L, Chieffo R, et al. Mult Scler. 2014 Mar 3. PMID: 24591532. Abstract
Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner. Oreja-Guevara C, Wiendl H, Kieseier BC, Airas L, for the NeuroNet Study Group Ther Adv Neurol Disord. 2014 Mar; 7(2):137-149. PMID: 24587828. Abstract
Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies. Tsivgoulis G, Sergentanis TN, Chan A, Voumvourakis K, Triantafyllou N, Psaltopoulou T, Gold R, Krogias C Ther Adv Neurol Disord. 2014 Mar; 7(2):114-136. PMID: 24587827. Abstract
A Case of Anti-aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló Concentric Lesions. Mori M, Masuda H Intern Med. 2014; 53(5):531. PMID: 24583454. Abstract
Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid. Long Y, Chen M, Zhang B, Gao C, Zheng Y, Xie L, Gao Q, Yin J J Neuroimmunol. 2014 Feb 16. PMID: 24582827. Abstract
Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis. Berkovich R, Agius MA Ther Adv Neurol Disord. 2014 Mar; 7(2):83-96. PMID: 24587825. Abstract
CNS inflammation other than multiple sclerosis: How likely is diagnosis? Street D, Halfpenny CA, Galea I Neurology. 2014 Feb 28. PMID: 24587479. Abstract
Plantarflexor weakness negatively impacts walking in persons with multiple sclerosis more than plantarflexor spasticity. Wagner JM, Kremer TR, Van Dillen LR, Naismith RT Arch Phys Med Rehabil. 2014 Feb 27. PMID: 24582617. Abstract
Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress. Bahamonde C, Conde C, Agüera E, Lillo R, Luque E, Gascón F, Feijóo M, Cruz AH, Sánchez-López F, Túnez I Eur J Pharmacol. 2014 Feb 25; 730C:26-30. PMID: 24582759. Abstract
First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks. Nicholas J A, Racke M K, Imitola J, Boster A L Ther Adv Chronic Dis. 2014 Mar; 5(2):62-68. PMID: 24587891. Abstract
Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis. Miyamoto K, Tanaka N, Moriguchi K, Ueno R, Kadomatsu K, Kitagawa H, Kusunoki S Glycobiology. 2014 Feb 28. PMID: 24584141. Abstract
Gait kinematics of people with Multiple Sclerosis and the acute application of Functional Electrical Stimulation. van der Linden ML, Scott SM, Hooper JE, Cowan P, Mercer TH Gait Posture. 2014 Feb 6. PMID: 24582514. Abstract
4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review. Jensen H B, Ravnborg M, Dalgas U, Stenager E Ther Adv Neurol Disord. 2014 Mar; 7(2):97-113. PMID: 24587826. Abstract
Novel insights into the development and maintenance of the blood-brain barrier. Engelhardt B, Liebner S Cell Tissue Res. 2014 Mar 4. Epub 2014 Mar 04. PMID: 24590145. Abstract
A subtraction pipeline for automatic detection of new appearing multiple sclerosis lesions in longitudinal studies. Ganiler O, Oliver A, Diez Y, Freixenet J, Vilanova JC, Beltran B, Ramió-Torrentà L, Rovira A, Lladó X Neuroradiology. 2014 Mar 4. Epub 2014 Mar 04. PMID: 24590302. Abstract
Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation. Shrestha B, Ge S, Pachter JS Fluids Barriers CNS. 2014; 11(1):6. Epub 2014 Mar 04. PMID: 24589378. Abstract
LINGO-1 regulates oligodendrocyte differentiation by inhibiting ErbB2 translocation and activation in lipid rafts. Lee X, Shao Z, Sheng G, Pepinsky B, Mi S Mol Cell Neurosci. 2014 Feb 28. PMID: 24583087. Abstract
Biomarkers for multiple sclerosis. Tomioka R, Matsui M Intern Med. 2014; 53(5):361-5. PMID: 24583421. Abstract
Anti-aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló's Concentric Lesions. Zhou C, Yang Y, Zhang H Intern Med. 2014; 53(5):529. PMID: 24583453. Abstract
Relapsing-Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells. Sasaki K, Bean A, Shah S, Schutten E, Huseby PG, Peters B, Shen ZT, Vanguri V, Liggitt D, Huseby ES J Immunol. 2014 Apr 1; 192(7):3029-42. Epub 2014 Mar 03. PMID: 24591371. Abstract
The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells. Ganor Y, Levite M J Neural Transm. 2014 Mar 2. Epub 2014 Mar 02. PMID: 24584970. Abstract
Sulfatide-mediated control of extracellular matrix-dependent oligodendrocyte maturation. Baron W, Bijlard M, Nomden A, de Jonge JC, Teunissen CE, Hoekstra D Glia. 2014 Feb 28. PMID: 24578319. Abstract
Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits. Lauer K Int J Mol Sci. 2014; 15(3):3533-45. PMID: 24577315. Abstract
Fast computation of myelin maps from MRI T2 relaxation data using multicore CPU and graphics card parallelization. Yoo Y, Prasloski T, Vavasour I, Mackay A, Traboulsee AL, Li DKB, Tam RC J Magn Reson Imaging. 2014 Feb 27. PMID: 24578324. Abstract
Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes. Mitjana R, Tintoré M, Rocca MA, Auger C, Barkhof F, Filippi M, Polman C, Fazekas F, Huerga E, Montalban X, et al. Mult Scler. 2014 Feb 27. PMID: 24576831. Abstract
Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab. Kitley J, Evangelou N, Küker W, Jacob A, Leite IM, Palace J J Neurol Sci. 2014 Feb 4. PMID: 24576801. Abstract
Adverse socioeconomic position during the life course is associated with multiple sclerosis. Briggs FBS, Acuña BS, Shen L, Bellesis KH, Ramsay PP, Quach H, Bernstein A, Schaefer C, Barcellos LF J Epidemiol Community Health. 2014 Feb 27. PMID: 24577137. Abstract
HLA-DRB1*15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer. Anagnostouli M, Anagnostoulis G, Katsavos S, Panagiotou M, Kararizou E, Davaki P J Neurol Sci. 2014 Feb 11. PMID: 24576802. Abstract
Optic and auditory pathway dysfunction in demyelinating neuropathies. Knopp M, Leese RJ, Martin-Lamb D, Rajabally YA Acta Neurol Scand. 2014 Feb 20. PMID: 24571608. Abstract
Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats. Bucher T, Dubreil L, Colle M-A, Maquigneau M, Deniaud J, Ledevin M, Moullier P, Joussemet B Gene Ther. 2014 Feb 27. PMID: 24572783. Abstract
Human Herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via TLR9. Reynaud JM, Jégou J-F, Welsch J, Horvat B J Virol. 2014 Feb 26. PMID: 24574405. Abstract
Treatment satisfaction, adherence and behavioral assessment in patients de - escalating from natalizumab to interferon beta. Zecca C, Riccitelli GC, Calabrese P, Pravatà E, Candrian U, Guttmann CRG, Gobbi C BMC Neurol. 2014; 14(1):38. Epub 2014 Feb 28. PMID: 24576156. Abstract
Targeting FcRn for therapy: From live cell imaging to in vivo studies in mice. Ward SE, Velmurugan R, Ober RJ Immunol Lett. 2014 Feb 23. PMID: 24572175. Abstract
Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression. Irizar H, Muñoz-Culla M, Sepúlveda L, Sáenz-Cuesta M, Prada A, Castillo-Triviño T, Zamora-López G, de Munain A L, Olascoaga J, Otaegui D PLoS One. 2014; 9(2):e90482. Epub 2014 Feb 28. PMID: 24587374. Abstract
Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis. Williams SK, Maier O, Fischer R, Fairless R, Hochmeister S, Stojic A, Pick L, Haar D, Musiol S, Storch MK, et al. PLoS One. 2014; 9(2):e90117. Epub 2014 Feb 28. PMID: 24587232. Abstract
Family studies of type 1 diabetes reveal additive and epistatic effects between MGAT1 and three other polymorphisms. Yu Z, Li CF, Mkhikian H, Zhou RW, Newton BL, Demetriou M Genes Immun. 2014 Feb 27. PMID: 24572742. Abstract
Modulation of subventricular zone oligodendrogenesis: a role for hemopressin? Xapelli S, Agasse F, Grade S, Bernardino L, Ribeiro FF, Schitine CS, Heimann AS, Ferro ES, Sebasti AM, De Melo Reis RA, et al. Front Cell Neurosci. 2014; 8:59. Epub 2014 Feb 27. PMID: 24578683. Abstract
Glatiramer acetate does not protect from acute ischemic stroke in mice. Kraft P, Göbel K, Meuth SG, Kleinschnitz C Exp Transl Stroke Med. 2014; 6(1):4. Epub 2014 Feb 27. PMID: 24576335. Abstract
Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis. Ghassemi R, Narayanan S, Banwell B, Sled JG, Shroff M, Arnold DL, Canadian Pediatric Demyelinating Disease Network PLoS One. 2014; 9(2):e85741. Epub 2014 Feb 26. PMID: 24586244. Abstract
Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors b20-4.1.1 and angiostatin (k1-3). Macmillan CJ, Doucette CD, Warford J, Furlong SJ, Hoskin DW, Easton AS PLoS One. 2014; 9(2):e89770. Epub 2014 Feb 26. PMID: 24587024. Abstract
Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways. Arnold P, Mojumder D, Detoledo J, Lucius R, Wilms H Clin Pharmacol. 2014; 6:35-42. Epub 2014 Feb 24. PMID: 24591852. Abstract
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta. Gavasso S, Mosleth E F, Marøy T, Jørgensen K, Nakkestad H-L, Gjertsen B-T, Myhr K-M, Vedeler C PLoS One. 2014; 9(2):e88632. Epub 2014 Feb 19. PMID: 24586361. Abstract
Inflammatory Cytokines and Physical Activity in Multiple Sclerosis. Florindo M ISRN Neurol. 2014; 2014:151572. Epub 2014 Jan 27. PMID: 24592334. Abstract
A Mushroom Extract Piwep from Phellinus igniarius Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Immune Cell Infiltration in the Spinal Cord. Li L, Wu G, Choi B Y, Jang B G, Kim J H, Sung G H, Cho J Y, Suh S W, Park H J Biomed Res Int. 2014; 2014:218274. Epub 2014 Jan 27. PMID: 24592383. Abstract
Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI. Messina S, Patti F Mult Scler Int. 2014; 2014:609694. Epub 2014 Jan 22. PMID: 24587905. Abstract
Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait. Lamdhade S, Ashkanani A, Alroughani R ISRN Neurol. 2014; 2014:861091. Epub 2014 Jan 22. PMID: 24587917. Abstract
Neurosarcoidosis mimicking multiple sclerosis successfully treated with methotrexate and adalimumab. Metyas S, Tawadrous M, Yeter KC, Arkfeld DG Int J Rheum Dis. 2014 Feb; 17(2):214-6. Epub 2013 Jul 02. PMID: 24576278. Abstract
Assessment of ovarian reserve and Doppler characteristics in patients with multiple sclerosis using immunomodulating drugs. Cil A P, Leventoğlu A, Sönmezer M, Soylukoç R, Oktay K J Turk Ger Gynecol Assoc. 2009; 10(4):213-9. Epub 2009 Dec 01. PMID: 24591875. Abstract
Multiple-Sklerose-Therapie-Konsensus-Gruppe Nervenarzt. 2002 Jun; 73(6):556-563. PMID: 24577618. Abstract